{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:22:40Z","timestamp":1791256960064,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T00:00:00Z","timestamp":1313107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T00:00:00Z","timestamp":1313107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/leu.2011.207","type":"journal-article","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T08:56:16Z","timestamp":1313139376000},"page":"244-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["CpG methylation patterns and decitabine treatment response in acute myeloid leukemia cells and normal hematopoietic precursors"],"prefix":"10.1038","volume":"26","author":[{"given":"S","family":"Negrotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K P","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Jankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Guinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J C","family":"Mulloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Maciejewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Saunthararajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,12]]},"reference":[{"key":"BFleu2011207_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0092-8674(83)90327-6","volume":"33","author":"DV Santi","year":"1983","unstructured":"Santi DV, Garrett CE, Barr PJ . On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs. Cell 1983; 33: 9\u201310.","journal-title":"Cell"},{"key":"BFleu2011207_CR2","first-page":"5511","volume":"46","author":"JM Covey","year":"1986","unstructured":"Covey JM, D'Incalci M, Tilchen EJ, Zaharko DS, Kohn KW . Differences in DNA damage produced by incorporation of 5-aza-2\u2032-deoxycytidine or 5,6-dihydro-5-azacytidine into DNA of mammalian cells. Cancer Res 1986; 46: 5511\u20135517.","journal-title":"Cancer Res"},{"key":"BFleu2011207_CR3","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1093\/nar\/gkm432","volume":"35","author":"L Schermelleh","year":"2007","unstructured":"Schermelleh L, Haemmer A, Spada F, Rosing N, Meilinger D, Rothbauer U et al. Dynamics of Dnmt1 interaction with the replication machinery and its role in postreplicative maintenance of DNA methylation. Nucleic Acids Res 2007; 35: 4301\u20134312.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2011207_CR4","first-page":"1636","volume":"37","author":"RL Momparler","year":"1977","unstructured":"Momparler RL, Goodman J . In vitro cytotoxic and biochemical effects of 5-aza-2\u2032-deoxycytidine. Cancer Res 1977; 37: 1636\u20131639.","journal-title":"Cancer Res"},{"key":"BFleu2011207_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0092-8674(80)90237-8","volume":"20","author":"PA Jones","year":"1980","unstructured":"Jones PA, Taylor SM . Cellular differentiation, cytidine analogs and DNA methylation. Cell 1980; 20: 85\u201393.","journal-title":"Cell"},{"key":"BFleu2011207_CR6","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1182\/blood-2003-07-2431","volume":"103","author":"M Milhem","year":"2004","unstructured":"Milhem M, Mahmud N, Lavelle D, Araki H, Desimone J, Saunthararajah Y et al. Modification of hematopoietic stem cell fate by 5aza 2\u2032deoxycytidine and trichostatin A. Blood 2004; 103: 4102\u20134110.","journal-title":"Blood"},{"key":"BFleu2011207_CR7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1158\/0008-5472.CAN-04-3011","volume":"65","author":"G Bug","year":"2005","unstructured":"Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 2005; 65: 2537\u20132541.","journal-title":"Cancer Res"},{"key":"BFleu2011207_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1080\/14653240410004899","volume":"6","author":"JC Young","year":"2004","unstructured":"Young JC, Wu S, Hansteen G, Du C, Sambucetti L, Remiszewski S et al. Inhibitors of histone deacetylases promote hematopoietic stem cell self-renewal. Cytotherapy 2004; 6: 328\u2013336.","journal-title":"Cytotherapy"},{"key":"BFleu2011207_CR9","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1182\/blood-2006-07-035287","volume":"109","author":"H Araki","year":"2007","unstructured":"Araki H, Yoshinaga K, Boccuni P, Zhao Y, Hoffman R, Mahmud N . Chromatin-modifying agents permit human hematopoietic stem cells to undergo multiple cell divisions while retaining their repopulating potential. Blood 2007; 109: 3570\u20133578.","journal-title":"Blood"},{"key":"BFleu2011207_CR10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1158\/0008-5472.CAN-04-3063","volume":"65","author":"L De Felice","year":"2005","unstructured":"De Felice L, Tatarelli C, Mascolo MG, Gregorj C, Agostini F, Fiorini R et al. Histone deacetylase inhibitor valproic acid enhances the cytokine-induced expansion of human hematopoietic stem cells. Cancer Res 2005; 65: 1505\u20131513.","journal-title":"Cancer Res"},{"key":"BFleu2011207_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1158\/1535-7163.MCT-10-0191","volume":"9","author":"Z Hu","year":"2010","unstructured":"Hu Z, Negrotto S, Gu X, Mahfouz R, Ng KP, Ebrahem Q et al. Decitabine maintains hematopoietic precursor self-renewal by preventing repression of stem cell genes by a differentiation-inducing stimulus. Mol Cancer Ther 2010; 9: 1536\u20131543.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2011207_CR12","doi-asserted-by":"publisher","first-page":"4968","DOI":"10.1182\/blood-2009-01-197780","volume":"114","author":"YS Chung","year":"2009","unstructured":"Chung YS, Kim HJ, Kim TM, Hong SH, Kwon KR, An S et al. Undifferentiated hematopoietic cells are characterized by a genome-wide undermethylation dip around the transcription start site and a hierarchical epigenetic plasticity. Blood 2009; 114: 4968\u20134978.","journal-title":"Blood"},{"key":"BFleu2011207_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/ajh.20178","volume":"77","author":"M Suzuki","year":"2004","unstructured":"Suzuki M, Harashima A, Okochi A, Yamamoto M, Nakamura S, Motoda R et al. 5-Azacytidine supports the long-term repopulating activity of cord blood CD34(+) cells. Am J Hematol 2004; 77: 313\u2013315.","journal-title":"Am J Hematol"},{"key":"BFleu2011207_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/ng.463","volume":"41","author":"AM Broske","year":"2009","unstructured":"Broske AM, Vockentanz L, Kharazi S, Huska MR, Mancini E, Scheller M et al. DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet 2009; 41: 1207\u20131215.","journal-title":"Nat Genet"},{"key":"BFleu2011207_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.stem.2009.08.016","volume":"5","author":"JJ Trowbridge","year":"2009","unstructured":"Trowbridge JJ, Snow JW, Kim J, Orkin SH . DNA methyltransferase 1 is essential for and uniquely regulates hematopoietic stem and progenitor cells. Cell Stem Cell 2009; 5: 442\u2013449.","journal-title":"Cell Stem Cell"},{"key":"BFleu2011207_CR16","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood.V64.4.922.922","volume":"64","author":"A Pinto","year":"1984","unstructured":"Pinto A, Attadia V, Fusco A, Ferrara F, Spada OA, Di Fiore PP . 5-Aza-2\u2032-deoxycytidine induces terminal differentiation of leukemic blasts from patients with acute myeloid leukemias. Blood 1984; 64: 922\u2013929.","journal-title":"Blood"},{"key":"BFleu2011207_CR17","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/S0021-9258(19)68144-5","volume":"257","author":"F Creusot","year":"1982","unstructured":"Creusot F, Acs G, Christman JK . Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2\u2032-deoxycytidine. J Biol Chem 1982; 257: 2041\u20132048.","journal-title":"J Biol Chem"},{"key":"BFleu2011207_CR18","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1182\/blood-2009-01-198911","volume":"113","author":"D Nowak","year":"2009","unstructured":"Nowak D, Stewart D, Koeffler HP . Differentiation therapy of leukemia: 3 decades of development. Blood 2009; 113: 3655\u20133665.","journal-title":"Blood"},{"key":"BFleu2011207_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1046\/j.1365-2141.2001.02523.x","volume":"112","author":"N Niitsu","year":"2001","unstructured":"Niitsu N, Hayashi Y, Sugita K, Honma Y . Sensitization by 5-aza-2\u2032-deoxycytidine of leukaemia cells with MLL abnormalities to induction of differentiation by all-trans retinoic acid and 1alpha,25-dihydroxyvitamin D3. Br J Haematol 2001; 112: 315\u2013326.","journal-title":"Br J Haematol"},{"key":"BFleu2011207_CR20","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/sj.leu.2401508","volume":"13","author":"H Kosugi","year":"1999","unstructured":"Kosugi H, Towatari M, Hatano S, Kitamura K, Kiyoi H, Kinoshita T et al. Histone deacetylase inhibitors are the potent inducer\/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. Leukemia 1999; 13: 1316\u20131324.","journal-title":"Leukemia"},{"key":"BFleu2011207_CR21","first-page":"2766","volume":"59","author":"J Wang","year":"1999","unstructured":"Wang J, Saunthararajah Y, Redner RL, Liu JM . Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. Cancer Res 1999; 59: 2766\u20132769.","journal-title":"Cancer Res"},{"key":"BFleu2011207_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1471-4892(03)00081-X","volume":"3","author":"AI Spira","year":"2003","unstructured":"Spira AI, Carducci MA . Differentiation therapy. Curr Opin Pharmacol 2003; 3: 338\u2013343.","journal-title":"Curr Opin Pharmacol"},{"key":"BFleu2011207_CR23","first-page":"461","volume":"46","author":"PA Jones","year":"1986","unstructured":"Jones PA . DNA methylation and cancer. Cancer Res 1986; 46: 461\u2013466.","journal-title":"Cancer Res"},{"key":"BFleu2011207_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1044-579X(02)00054-8","volume":"12","author":"J Lotem","year":"2002","unstructured":"Lotem J, Sachs L . Epigenetics wins over genetics: induction of differentiation in tumor cells. Semin Cancer Biol 2002; 12: 339\u2013346.","journal-title":"Semin Cancer Biol"},{"key":"BFleu2011207_CR25","doi-asserted-by":"publisher","first-page":"12371","DOI":"10.1073\/pnas.0704468104","volume":"104","author":"JL Attema","year":"2007","unstructured":"Attema JL, Papathanasiou P, Forsberg EC, Xu J, Smale ST, Weissman IL . Epigenetic characterization of hematopoietic stem cell differentiation using miniChIP and bisulfite sequencing analysis. Proc Natl Acad Sci USA 2007; 104: 12371\u201312376.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011207_CR26","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1182\/blood-2008-06-163246","volume":"113","author":"Y Jiang","year":"2009","unstructured":"Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009; 113: 1315\u20131325.","journal-title":"Blood"},{"key":"BFleu2011207_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1182\/blood.V99.1.15","volume":"99","author":"JC Mulloy","year":"2002","unstructured":"Mulloy JC, Cammenga J, MacKenzie KL, Berguido FJ, Moore MA, Nimer SD . The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 2002; 99: 15\u201323.","journal-title":"Blood"},{"key":"BFleu2011207_CR28","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1101\/gr.4410706","volume":"16","author":"M Bibikova","year":"2006","unstructured":"Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16: 383\u2013393.","journal-title":"Genome Res"},{"key":"BFleu2011207_CR29","doi-asserted-by":"publisher","first-page":"15785","DOI":"10.1073\/pnas.0507816102","volume":"102","author":"M Ehrich","year":"2005","unstructured":"Ehrich M, Nelson MR, Stanssens P, Zabeau M, Liloglou T, Xinarianos G et al. Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc Natl Acad Sci USA 2005; 102: 15785\u201315790.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011207_CR30","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/nar\/26.1.362","volume":"26","author":"T Heinemeyer","year":"1998","unstructured":"Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362\u2013367.","journal-title":"Nucleic Acids Res"},{"key":"BFleu2011207_CR31","doi-asserted-by":"publisher","first-page":"e6986","DOI":"10.1371\/journal.pone.0006986","volume":"4","author":"JI Martin-Subero","year":"2009","unstructured":"Martin-Subero JI, Ammerpohl O, Bibikova M, Wickham-Garcia E, Agirre X, Alvarez S et al. A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms. PLoS ONE 2009; 4: e6986.","journal-title":"PLoS ONE"},{"key":"BFleu2011207_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.immuni.2007.06.004","volume":"26","author":"H Iwasaki","year":"2007","unstructured":"Iwasaki H, Akashi K . Myeloid lineage commitment from the hematopoietic stem cell. Immunity 2007; 26: 726\u2013740.","journal-title":"Immunity"},{"key":"BFleu2011207_CR33","doi-asserted-by":"publisher","first-page":"13187","DOI":"10.1073\/pnas.94.24.13187","volume":"94","author":"R Yamanaka","year":"1997","unstructured":"Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, Eckhaus M et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT\/enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 1997; 94: 13187\u201313192.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011207_CR34","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1182\/blood-2004-08-3346","volume":"105","author":"K Theilgaard-Monch","year":"2005","unstructured":"Theilgaard-Monch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, Nielsen FC et al. The transcriptional program of terminal granulocytic differentiation. Blood 2005; 105: 1785\u20131796.","journal-title":"Blood"},{"key":"BFleu2011207_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/gcc.20500","volume":"47","author":"DL Stirewalt","year":"2008","unstructured":"Stirewalt DL, Meshinchi S, Kopecky KJ, Fan W, Pogosova-Agadjanyan EL, Engel JH et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosomes Cancer 2008; 47: 8\u201320.","journal-title":"Genes Chromosomes Cancer"},{"key":"BFleu2011207_CR36","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/1471-2164-8-264","volume":"8","author":"F Ferrari","year":"2007","unstructured":"Ferrari F, Bortoluzzi S, Coppe A, Basso D, Bicciato S, Zini R et al. Genomic expression during human myelopoiesis. BMC Genomics 2007; 8: 264.","journal-title":"BMC Genomics"},{"key":"BFleu2011207_CR37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1056\/NEJMoa040465","volume":"350","author":"PJ Valk","year":"2004","unstructured":"Valk PJ, Verhaak RG, Beijen MA, Erpelinck CA, Barjesteh van Waalwijk van Doorn-Khosrovani S, Boer JM et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004; 350: 1617\u20131628.","journal-title":"N Engl J Med"},{"key":"BFleu2011207_CR38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1365-2141.2008.07431.x","volume":"144","author":"AM Cheung","year":"2009","unstructured":"Cheung AM, Chow HC, Liang R, Leung AY . A comparative study of bone marrow and peripheral blood CD34+ myeloblasts in acute myeloid leukaemia. Br J Haematol 2009; 144: 484\u2013491.","journal-title":"Br J Haematol"},{"key":"BFleu2011207_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1182\/blood-2005-12-4769","volume":"108","author":"A Pellagatti","year":"2006","unstructured":"Pellagatti A, Cazzola M, Giagounidis AA, Malcovati L, Porta MG, Killick S et al. Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype. Blood 2006; 108: 337\u2013345.","journal-title":"Blood"},{"key":"BFleu2011207_CR40","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1073\/pnas.0900089106","volume":"106","author":"R Majeti","year":"2009","unstructured":"Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R et al. Dysregulated gene expression networks in human acute myelogenous leukemia stem cells. Proc Natl Acad Sci USA 2009; 106: 3396\u20133401.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2011207_CR41","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1182\/blood.V98.4.897","volume":"98","author":"H Nakajima","year":"2001","unstructured":"Nakajima H, Ihle JN . Granulocyte colony-stimulating factor regulates myeloid differentiation through CCAAT\/enhancer-binding protein epsilon. Blood 2001; 98: 897\u2013905.","journal-title":"Blood"},{"key":"BFleu2011207_CR42","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1182\/blood-2007-10-118331","volume":"112","author":"DC Taussig","year":"2008","unstructured":"Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C et al. Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood 2008; 112: 568\u2013575.","journal-title":"Blood"},{"key":"BFleu2011207_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ccr.2008.02.008","volume":"13","author":"P Kirstetter","year":"2008","unstructured":"Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H, Kurz E et al. Modeling of C\/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 2008; 13: 299\u2013310.","journal-title":"Cancer Cell"},{"key":"BFleu2011207_CR44","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","volume":"6","author":"BJ Huntly","year":"2004","unstructured":"Huntly BJ, Shigematsu H, Deguchi K, Lee BH, Mizuno S, Duclos N et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004; 6: 587\u2013596.","journal-title":"Cancer Cell"},{"key":"BFleu2011207_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ccr.2006.08.020","volume":"10","author":"TC Somervaille","year":"2006","unstructured":"Somervaille TC, Cleary ML . Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. Cancer Cell 2006; 10: 257\u2013268.","journal-title":"Cancer Cell"},{"key":"BFleu2011207_CR46","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/sj.leu.2404754","volume":"21","author":"A van Rhenen","year":"2007","unstructured":"van Rhenen A, Moshaver B, Kelder A, Feller N, Nieuwint AW, Zweegman S et al. Aberrant marker expression patterns on the CD34+. Leukemia 2007; 21: 1700\u20131707.","journal-title":"Leukemia"},{"key":"BFleu2011207_CR47","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1182\/blood.V89.9.3104","volume":"89","author":"A Blair","year":"1997","unstructured":"Blair A, Hogge DE, Ailles LE, Lansdorp PM, Sutherland HJ . Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo. Blood 1997; 89: 3104\u20133112.","journal-title":"Blood"},{"key":"BFleu2011207_CR48","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/S0301-472X(00)00155-7","volume":"28","author":"A Blair","year":"2000","unstructured":"Blair A, Sutherland HJ . Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117). Exp Hematol 2000; 28: 660\u2013671.","journal-title":"Exp Hematol"},{"key":"BFleu2011207_CR49","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/leu.2010.158","volume":"24","author":"M Wunderlich","year":"2010","unstructured":"Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M et al. AML xenograft efficiency is significantly improved in NOD\/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3. Leukemia 2010; 24: 1785\u20131788.","journal-title":"Leukemia"},{"key":"BFleu2011207_CR50","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/sj.leu.2402882","volume":"17","author":"M Feuring-Buske","year":"2003","unstructured":"Feuring-Buske M, Gerhard B, Cashman J, Humphries RK, Eaves CJ, Hogge DE . Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD\/SCID mice and in NOD\/SCID mice transgenic for human growth factors. Leukemia 2003; 17: 760\u2013763.","journal-title":"Leukemia"},{"key":"BFleu2011207_CR51","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1002\/ijc.23772","volume":"123","author":"A Agliano","year":"2008","unstructured":"Agliano A, Martin-Padura I, Mancuso P, Marighetti P, Rabascio C, Pruneri G et al. Human acute leukemia cells injected in NOD\/LtSz-scid\/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD\/SCID-related strains. Int J Cancer 2008; 123: 2222\u20132227.","journal-title":"Int J Cancer"},{"key":"BFleu2011207_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1172\/JCI41495","volume":"121","author":"JE Sarry","year":"2011","unstructured":"Sarry JE, Murphy K, Perry R, Sanchez PV, Secreto A, Keefer C et al. Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD\/SCID\/IL2Rgammac-deficient mice. J Clin Invest 2011; 121: 384\u2013395.","journal-title":"J Clin Invest"},{"key":"BFleu2011207_CR53","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1182\/blood-2006-08-040147","volume":"109","author":"S Agrawal","year":"2007","unstructured":"Agrawal S, Hofmann WK, Tidow N, Ehrich M, van den BD, Koschmieder S et al. The C\/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia. Blood 2007; 109: 3895\u20133905.","journal-title":"Blood"},{"key":"BFleu2011207_CR54","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1182\/blood-2010-10-312512","volume":"117","author":"Z Hu","year":"2011","unstructured":"Hu Z, Gu X, Baraoidan K, Ibanez V, Sharma A, Kadkol S et al. RUNX1 regulates corepressor interactions of PU.1. Blood 2011; 117: 6498\u20136508.","journal-title":"Blood"},{"key":"BFleu2011207_CR55","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/1471-2407-10-401","volume":"10","author":"J Rocquain","year":"2010","unstructured":"Rocquain J, Carbuccia N, Trouplin V, Raynaud S, Murati A, Nezri M et al. Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC Cancer 2010; 10: 401.","journal-title":"BMC Cancer"},{"key":"BFleu2011207_CR56","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2010.20","volume":"24","author":"J Boultwood","year":"2010","unstructured":"Boultwood J, Perry J, Pellagatti A, Fernandez-Mercado M, Fernandez-Santamaria C, Calasanz MJ et al. Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia. Leukemia 2010; 24: 1062\u20131065.","journal-title":"Leukemia"},{"key":"BFleu2011207_CR57","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1038\/leu.2010.167","volume":"24","author":"H Makishima","year":"2010","unstructured":"Makishima H, Jankowska AM, Tiu RV, Szpurka H, Sugimoto Y, Hu Z et al. Novel homo- and hemizygous mutations in EZH2 in myeloid malignancies. Leukemia 2010; 24: 1799\u20131804.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011207","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011207.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:29:08Z","timestamp":1648736948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,12]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFleu2011207"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.207","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,12]]},"assertion":[{"value":"5 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}